Speaker: Jenna Frame, Ph.D. Sr. Manager, Scientific Communications & Marketing, Biocytogen Boston

Inflammatory disease models are important preclinical research tools to study disease pathogenesis and uncover novel treatments. To directly evaluate the efficacy and safety of therapeutic drug candidates targeting these disorders, we can establish disease in wild-type and/or humanized mouse models. In this webinar, we will discuss Biocytogen’s capability to experimentally model diseases caused by inflammation/injury of the joint, lung and kidney, including arthritis models, SLE, and pulmonary fibrosis.